Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

TCT 2021 | Anti-CD117 mAb synergizes with 5-azacytidine to augment engraftment of HSCs in mice

Andriyana K. Bankova, MD, Stanford University School of Medicine, Stanford, CA, explores the use of a CD117-targeting monoclonal antibody (mAb) in combination with azacytidine to augment engraftment of hematopoietic stem cells (HSCs) in a mice model. This interview took place during the Transplantation & Cellular Therapy (TCT) 2021 Meetings.